Navigation Links
Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
Date:6/30/2009

SAN DIEGO, June 30 /PRNewswire/ -- Calixa Therapeutics Inc. today announced the initiation of a Phase 2 clinical trial of CXA-101 in patients with complicated urinary tract infections. CXA-101 is a new broad-spectrum, parenteral cephalosporin antibiotic with excellent in vitro and in vivo activity against Pseudomonas aeruginosa, including drug resistant isolates. Calixa is investigating CXA-101 as a potential treatment for serious bacterial infections in hospitalized patients.

The multi-center, randomized study is anticipated to enroll approximately 120 patients and will compare the efficacy and safety of CXA-101 with the current standard of therapy. The primary efficacy endpoint for this study is microbiological outcome at the test-of-cure visit between six to nine days after the end of therapy.

"The preclinical and Phase 1 results to date are very promising and indicate that CXA-101 is well tolerated and has broad-spectrum antibacterial coverage, including potent activity against increasingly resistant gram-negative pathogens such as Pseudomonas aeruginosa," said Dr. Ian Friedland, chief medical officer of Calixa. "We are going to present comprehensive preclinical and Phase 1 data at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy in September and other medical conferences. This Phase 2 study will generate important information on the safety and effectiveness of CXA-101 in complicated urinary tract infections, which are usually caused by gram-negative pathogens".

Eckard Weber, president and chief executive officer of Calixa and partner at the venture capital firm Domain Associates, LLC said, "With the continually increasing incidence of serious and life-threatening infections caused by resistant gram-negative bacteria and the paucity of new drugs in the pipeline to counter such
'/>"/>

SOURCE Calixa Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
4. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
5. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
6. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
7. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
8. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
9. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
10. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
11. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 ... Research "Process Spectroscopy Market (Technology Types - Near infrared (NIR) ... - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... million in 2012 and is expected to grow at a ... North America was the largest contributor to ...
(Date:7/22/2014)... July 22, 2014 The number of people ... people each day. Twenty-three percent of the workforce has ... Drug Use and Health, making opioid use a serious ... opioid painkillers at the correct dosage with a valid ... Today, the National Safety Council released a ...
(Date:7/22/2014)... 2014 BiologicTx ® today announced their ... Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary matching ... 9 at the Miami Transplant Institute, located at Jackson ... Kidney Paired Donation (KPD) is an ... kidney transplant with one another due to incompatible blood ...
Breaking Medicine Technology:Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 45 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3
... March 14, 2011 Streamline Health Solutions, Inc. (Nasdaq: ... document workflow solutions for hospitals, announced today that Rick ... Marketing Officer effective March 14, 2011. With more than ... to Streamline Health an extensive background in developing and ...
... the animal health division of Eli Lilly and Company ... has made an irrevocable, unconditional offer to acquire the ... & Johnson Company. The two companies have notified the ... Beerse, Belgium, Janssen,s animal health business is primarily European-focused, ...
Cached Medicine Technology:Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer 2Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer 3Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer 4Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 2Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 3
(Date:7/23/2014)... (PRWEB) July 23, 2014 In an ... Plan to Address Alzheimer’s Disease” at the state level, ... the Alzheimer’s Foundation of America (AFA) this ... of the Alzheimer’s crisis, and the need for wide-scale ... to those localities. , The white paper ...
(Date:7/23/2014)... --- Controlling pain during childbirth and post delivery may ... M.D., a Northwestern Medicine perinatal psychiatrist, in a July ... , Wisner,s editorial is based on a new Chinese ... epidural anesthesia during a vaginal delivery had a much ... have the epidural. , "Maximizing pain control in labor ...
(Date:7/22/2014)... 2014 Ticket Down is a ... City tickets at Sporting Park in Kansas City, MO. ... July 23rd. Tickets can be conveniently printed out for ... Down can be reached toll free at 1-877-870-3653. All ... and covered by Ticket Down's customer satisfaction guarantee. , About ...
(Date:7/22/2014)... Francisco, CA (PRWEB) July 22, 2014 ... producing products for consumers to buy can now reduce ... Cherry News company has released its cosmetic buying guide ... under eyes at http://cherrynews.com/best-nourishing-eye-serum . , This guide ... who suffer from the different under eye circles that ...
(Date:7/22/2014)... 22, 2014 DocbookMD , a ... deploying one of the largest physician-centric mobile communication solutions ... ) in Houston. , Created by Austin-based physicians, Tracey ... application will be embedded into MHMD’s Accountable Care Network ... the best technology to put this capability at the ...
Breaking Medicine News(10 mins):Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Controlling childbirth pain tied to lower depression risk 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4
... FRANCISCO, May 11 Today,s announcement takes shared responsibility ... are committing to share responsibility for saving $2 trillion ... they succeed, affordable coverage for all is within our ... coverage based on universal responsibility. We are pleased ...
... a change of pace for cardiac rehab programs, , , MONDAY, ... who are overweight, longer but slower walks are better for ... a new study has found. , Frequent long, slow walks ... moderate pace, five to six days a week -- were ...
... United States Agency for International Development (USAID) announced today ... activities in Kenya would rise to $17.8 million in ... to USAID,s family planning and reproductive health activities in ... the Government of Kenya,s efforts to increase access to ...
... The Texas Cardiac Arrhythmia Institute (TCAI) at St. David,s ... heart rhythm disorders since it launched on May 1, ... Central Texas."In just one year, the physician team at ... Center, coupled with our unmatched level of technology, has ...
... Thermofocus(R) 5-in-1WESTON, Fla., May 11 American Scientific Resources, ... for the first quarter ending March 31, 2009. ... sales of $263,603 for the first quarter of 2009, ... first quarter of 2008.The sales increase was predominantly due ...
... 11 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, Inc. (OTC Bulletin Board: GNPH) ... in the People,s Republic,of China, today announced that its ... Board under the new ticker symbol "JGBO" as of ... the ticker symbol "GNPH" at the,end of May 11, ...
Cached Medicine News:Health News:Walk Long, Slow and Often to Help the Heart 2Health News:Walk Long, Slow and Often to Help the Heart 3Health News:U.S. Increases Funding for Kenya's Family Planning and Reproductive Health Activities 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 3Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 4Health News:American Scientific Resources, Inc. Releases First Quarter Revenues 2Health News:Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP 2
... Arctic Circler uses the same cryoconsole ... AF originating in the pulmonary veins. Arctic ... challenge the traditional palliative-only treatments that rely ... the Arctic Circler catheter has the ability ...
... The Guglielmi Detachable Coil is intended for: ... because of,their morphology, their location, or the ... by the treating,neurosurgical team to be a) ... operative techniques, or b) inoperable.,The GDC is ...
Care must be taken to operate the power unit slowly to help eliminate the possibility of breaking the wires by over-tightening....
Large solid mallet with patented Ortho-Grip® silicone rubber handle....
Medicine Products: